These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 22591213)

  • 21. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
    Corrigan DO; Corrigan OI; Healy AM
    Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excipient-free nanoporous microparticles of budesonide for pulmonary delivery.
    Nolan LM; Tajber L; McDonald BF; Barham AS; Corrigan OI; Healy AM
    Eur J Pharm Sci; 2009 Jul; 37(5):593-602. PubMed ID: 19463948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of spray drying process parameters on the solubility behavior and physical stability of solid dispersions prepared using a laboratory-scale spray dryer.
    Kojima Y; Ohta T; Shiraki K; Takano R; Maeda H; Ogawa Y
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1484-93. PubMed ID: 22670826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Synergetic Effects of Nonpolar and Polar Protic Solvents on the Properties of Felodipine and Soluplus in Solutions, Casting Films, and Spray-Dried Solid Dispersions.
    Chen Y; Huang W; Chen J; Wang H; Zhang S; Xiong S
    J Pharm Sci; 2018 Jun; 107(6):1615-1623. PubMed ID: 29454624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nano-amorphous spray dried powder to improve oral bioavailability of itraconazole.
    Kumar S; Shen J; Burgess DJ
    J Control Release; 2014 Oct; 192():95-102. PubMed ID: 25009979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solution-state polymer assemblies influence BCS class II drug dissolution and supersaturation maintenance.
    Dalsin MC; Tale S; Reineke TM
    Biomacromolecules; 2014 Feb; 15(2):500-11. PubMed ID: 24328187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biorelevant in vitro dissolution testing of products containing micronized or nanosized fenofibrate with a view to predicting plasma profiles.
    Juenemann D; Jantratid E; Wagner C; Reppas C; Vertzoni M; Dressman JB
    Eur J Pharm Biopharm; 2011 Feb; 77(2):257-64. PubMed ID: 21074611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and delivery of improved amorphous fenofibrate solid dispersions prepared by thin film freezing.
    Zhang M; Li H; Lang B; O'Donnell K; Zhang H; Wang Z; Dong Y; Wu C; Williams RO
    Eur J Pharm Biopharm; 2012 Nov; 82(3):534-44. PubMed ID: 22974985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization and dissolution performance of spray-dried naproxen nano-crystals.
    Kumar S; Shen J; Zolnik B; Sadrieh N; Burgess DJ
    Int J Pharm; 2015; 486(1-2):159-66. PubMed ID: 25814034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based Formulation.
    Suys EJA; Chalmers DK; Pouton CW; Porter CJH
    Mol Pharm; 2018 Jun; 15(6):2355-2371. PubMed ID: 29659287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superiority of Mesoporous Silica-Based Amorphous Formulations over Spray-Dried Solid Dispersions.
    Zhang H; Li M; Li J; Agrawal A; Hui HW; Liu D
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hot Melt Extrusion and Spray Drying of Co-amorphous Indomethacin-Arginine With Polymers.
    Lenz E; Löbmann K; Rades T; Knop K; Kleinebudde P
    J Pharm Sci; 2017 Jan; 106(1):302-312. PubMed ID: 27817830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving the solubility of nilotinib through novel spray-dried solid dispersions.
    Herbrink M; Schellens JHM; Beijnen JH; Nuijen B
    Int J Pharm; 2017 Aug; 529(1-2):294-302. PubMed ID: 28689964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation parameters of crystalline nanosuspensions on spray drying processing: a DoE approach.
    Kumar S; Xu X; Gokhale R; Burgess DJ
    Int J Pharm; 2014 Apr; 464(1-2):34-45. PubMed ID: 24447788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production and characterization of a spray-dried hydroxypropyl-beta-cyclodextrin/quercetin complex.
    Zheng Y; Chow AH
    Drug Dev Ind Pharm; 2009 Jun; 35(6):727-34. PubMed ID: 19514988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Spray-Dried Dispersions in Early Pharmaceutical Development: Theoretical and Practical Challenges.
    Li J; Patel D; Wang G
    AAPS J; 2017 Mar; 19(2):321-333. PubMed ID: 27896684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility.
    Mou D; Chen H; Wan J; Xu H; Yang X
    Int J Pharm; 2011 Jul; 413(1-2):237-44. PubMed ID: 21540090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of fillers on dissolution kinetic of fenofibrate dry foams.
    Lenz E; Sprunk A; Kleinebudde P; Page S
    Pharm Dev Technol; 2015; 20(5):570-8. PubMed ID: 24901031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissolution-rate enhancement of fenofibrate by adsorption onto silica using supercritical carbon dioxide.
    Sanganwar GP; Gupta RB
    Int J Pharm; 2008 Aug; 360(1-2):213-8. PubMed ID: 18550302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.